Skip to content

Clinical trials

Phase 1/2 Eye Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 1/2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20112
20122
20151
20172
20182
20194
20202
20211
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated7
Active, not recruiting5
Recruiting5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AsclepiX Therapeutics, Inc.2
ProQR Therapeutics2
Sanwa Kagaku Kenkyusho Co., Ltd.2
SparingVision2
Beacon Therapeutics1
David M. Brown, M.D.1
Elisigen, Inc.1
Eyestem Research Pvt. Ltd.1
GenSight Biologics1
Gyroscope Therapeutics Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases27
Retinal Diseases16
Retinal Degeneration10
Macular Degeneration8
Retinitis Pigmentosa8
Eye Diseases, Hereditary6
Vision Disorders6
Retinal Dystrophies4
Cone-Rod Dystrophies3
Autoimmune Diseases2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.